| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.881 | 24.596 | 28.907 | 28.401 | 35.554 | 38.226 | 34.697 | 60.775 | 44.766 | 19.763 |
| Total Income - EUR | 23.883 | 24.596 | 28.907 | 28.401 | 35.554 | 38.226 | 34.697 | 60.775 | 44.766 | 27.211 |
| Total Expenses - EUR | 12.518 | 11.367 | 12.072 | 16.062 | 22.291 | 19.311 | 15.439 | 24.293 | 17.912 | 25.483 |
| Gross Profit/Loss - EUR | 11.365 | 13.229 | 16.835 | 12.339 | 13.264 | 18.915 | 19.259 | 36.483 | 26.854 | 1.728 |
| Net Profit/Loss - EUR | 10.648 | 12.736 | 16.546 | 12.055 | 12.908 | 18.533 | 18.911 | 35.875 | 26.407 | 1.455 |
| Employees | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 |
Check the financial reports for the company - Nicomed Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 131 | 0 | 521 | 1.599 | 1.046 | 1.680 | 1.662 | 5.069 | 3.436 | 6.966 |
| Current Assets | 8.911 | 12.076 | 15.476 | 26.680 | 39.214 | 56.449 | 64.443 | 87.527 | 39.288 | 9.244 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.203 | 593 | 678 | 401 | 456 | 448 | 438 | 753 | 12.322 | 6.063 |
| Cash | 7.708 | 11.482 | 14.799 | 26.279 | 38.758 | 56.001 | 64.005 | 86.773 | 26.966 | 3.181 |
| Shareholders Funds | 8.125 | 11.402 | 15.234 | 27.010 | 39.395 | 57.181 | 65.176 | 91.443 | 41.761 | 15.452 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 918 | 800 | 762 | 1.269 | 925 | 947 | 929 | 1.153 | 963 | 1.022 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicomed Plus S.r.l.